Dolby Laboratories (NYSE: DLB) reported earnings on May 3. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended March 30 (Q2), Dolby Laboratories beat expectations on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue expanded and GAAP earnings per share improved.

Gross margins grew, operating margins contracted, net margins grew.

Revenue details
 Dolby Laboratories logged revenue of $260.3 million. The 10 analysts polled by S&P Capital IQ expected a top line of $253.0 million on the same basis. GAAP reported sales were 4.1% higher than the prior-year quarter's $250.0 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $0.91. The eight earnings estimates compiled by S&P Capital IQ forecast $0.80 per share. GAAP EPS of $0.81 for Q2 were 13% higher than the prior-year quarter's $0.72 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 90.9%, 230 basis points better than the prior-year quarter. Operating margin was 46.9%, 130 basis points worse than the prior-year quarter. Net margin was 33.9%, 110 basis points better than the prior-year quarter.

Looking ahead
 Next quarter's average estimate for revenue is $219.4 million. On the bottom line, the average EPS estimate is $0.60.

Next year's average estimate for revenue is $943.4 million. The average EPS estimate is $2.86.

Investor sentiment
 The stock has a five-star rating (out of five) at Motley Fool CAPS, with 3,981 members out of 4,075 rating the stock outperform, and 95 members rating it underperform. Among 1,157 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 1,138 give Dolby Laboratories a green thumbs-up, and 19 give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Dolby Laboratories is hold, with an average price target of $41.71.